Introduction
The trend in ethics policy is to promote the view that people have the right to decide for themselves whether or not they wish to be informed about, for example, genetic high-risk status. The Universal Declaration on the Human Genome and Human Rights, issued by the UNESCO in 1997, says in Article 5 (c) that 'The right of each individual to decide whether or not to be informed about the results of genetic examination y should be respected'. 1 The WHO and the Council of Europe also recognise the right to remain in ignorance: 'the wish of individuals and families not to know genetic information, including test results, should be respected', and 'Everyone is entitled to know any information collected about his or her health. However, the wishes of individuals not to be so informed shall be observed'. 2 -3 Other documents stating this have been issued by the Nuffield Council on Bioethics, the Council of Europe, the World Medical Association, and the British Medical Association. 4 -7 From the formal language used in some of the ethical and legal instruments, researchers may well draw the conclusion that it implies an entitlement or absolute right that overrides other claims or interests involved. However, it must be questioned whether this was, or should have been, the intention of policy makers.
In the bioethical debate, it is widely agreed that individuals may have a legitimate interest in not wanting to know certain facts about their personal health such as their genetic status, the idea being that if there is an indication that an individual does not wish to know, then this wish should be respected by others, unless there is risk of harm to third parties. In such cases, disclosure may be ethically justified. 8 -11 Although this 'interest' or 'right' is originally modelled from the idea of an autonomous individual who decides upon matters important to his or her own health, 12 it is also often claimed to be justified from the viewpoint of the right to a private sphere. 13 -15 When discussing the right not to know there are two important points to consider. First, the notion of a right or interest in not knowing is mainly discussed in relation to situations involving individuals -examples given usually concern predisposition or carrier tests. While acknowledging the importance of such contexts, we must also remember that genetic and other high-risk information also occurs in other clinical contexts, for example, largescale population screening and predictive screening for disease markers. Those contexts usually involve the inclusion of whole families, including children (who have legitimate interests/developing agency even though they have a limited autonomy). 16 -20 Today such considerations have led to a dawning realisation since we might have obligations to disclose information to biological relatives, that we live in social relationships that make moral demands on us. To care for those whom we feel responsible for might often presuppose that we share the information we have, something that goes against the emphasis on a right not to know. We therefore need to think again about the values we find important when involving people in research, not least about the right not to know. 21 -24 Second, the comparative lack in some ethical guidelines and reports of a discussion regarding how interests should be balanced might be explained by the absence of empirical data, which has led to the predominant use of hypothetical situations with hypothetical persons. In order to properly evaluate the moral significance of a presumed 'right', 'wish' or 'interest' not to know one's genetic or other high-risk status, we need to know more about the empirical base, about what motives people have for such wishes or choices, especially since the research contexts where such decisions are made are increasingly diverse. This article begins to address this need for data.
As disclosure of high risk is a precondition for obtaining informed consent to potential future high-risk follow-up, we asked participants beforehand about their attitude towards being informed in case their child would belong to the high-risk group. The clinical study cohort consisted of 7206 families in their fifth year of participation in the ABIS study (All Babies in South-East Sweden), a longitudinal predictive screening for type 1 diabetes (T1DM). Two percent (n ¼ 142) of the respondents reported that they did not want to know, regardless of whether any intervention or prevention measures were available. In this paper, we explore this group further. This study is part of a larger multi-disciplinary project aiming to analyse and suggest criteria for information, consent and disclosure issues in Swedish longitudinal medical research involving children.
Methods
The data used in this paper originates from ABIS (All Babies in Southeast Sweden), a longitudinal predictive screening for risk of T1DM and its association to environmental factors, which has followed a large birth cohort since 1997 (n ¼ 17 055). 25 -26 Clinical data have been collected through diary, extensive questionnaires (at birth, 1 year, 2.5 -3 years, and 5 -6 years) and biological samples (cord and capillary blood, hair, stool, saliva, urine). The questionnaires contained questions concerning medical history, nutrition, demographic background, environmental issues, psychosocial history/psychological variables, including bioethical issues, that is, a comprehensive survey regarding the family including the child's, natural history. Children with increased risk (and thus eligible for followup studies) are identified by family history of T1DM, diabetes-associated HLA genotypes, and positivity for combinations of diabetes-related autoantibodies (IA-2, GAD, and IAA). Since recent research has revealed development of T1DM in individuals with a protective genotype, each of the three predictors for high risk may be of interest for follow-up studies. 27 -29 At 2.5 years, 531 children in the study cohort were positive for either GAD or IA-2, and 33 children were positive for both GAD and IA-2 (495th percentile). Over 9% of these 531 children had a T1DM family history. At 5 years, 415 of the children were positive for one of the two. Sixteen were double positive (490th percentile).
During the prospective phase (1997 -2005) the research design included non-disclosure. As research currently has led to the identification of preliminary risk groups, the participants were asked in the clinical questionnaire about their view on disclosing the child's risk status. While 98% of the respondent families wished to be informed about potential high-risk status, 2% of the respondents (n ¼ 142) did not.
Of the 142 families that did not want to know, nine (6.3%) had a first generation family history of T1DM, six had children with increased risk at 2.5 years based on being positive for autoantibodies (GAD). At 5 years, eight of the 142 families had children double positive for GAD/IA-2 (490th percentile), two with increased risk through both family history and GAD.
The 5-year extensive clinical questionnaire contains 180 questions accounting for the families' natural history of the past 2.5 -3 years. To assess the preconditions of 'The right not to know' U Swartling et al disclosure and follow-up of high-risk families the question 'Do you wish to be informed if your child is identified as having high risk of developing T1DM?' was incorporated in the clinical questionnaire. Three alternatives were given (total n ¼ 7206):
1. No, I/we do not want to be informed (2.0%, n ¼ 142). 2. Yes, I/we want to be informed if there is an effective prevention/intervention measure (24.1%, n ¼ 1736). 3. Yes, I/we want to be informed regardless of any available intervention/prevention (73.9%, n ¼ 5328).
Potential correlates to the dependent variable were assessed as those being theoretically relevant to highrisk disclosure (disease history, family history of T1DM, demographic background variables, psychosocial variables including socio-economic status, severe life events, research-ethical factors and maternal worries). This study was approved by the ethical committees at Linkoping University and Lund University (Li 03 -629; LU 1051 -03).
Derived variables
The majority of answers to the extensive list of questions regarding the families' natural history in the main clinical questionnaire were given at a 6-point Likert scale. For analysis, they were transformed into nominal or ordinal variables. Family history of T1DM was defined as within first -second generation. Birth complications were defined as prenatal complications: caesarean, NICU (Neonatal Intensive Care Unit), premature birth (o36 weeks). The child's disease development was defined as whether the child had developed a serious or chronic disease: T1DM, celiac disease, IBD/Crohn's, uveit/irit, child RA, IBD/ ulcerous colitis, psychiatric or other. Maternal concerns were defined as (a) concern/worry that the child would develop a severe/chronic disease or become seriously ill or (b) concern/worry that the child would become injured or handicapped or develop abnormally. Disease variables were derived from the extensive list of multifactor/genetically linked/other severe or chronic diseases incorporated in the main questionnaire. Parental satisfaction was defined as self-reported estimation of whether they regarded themselves as good parents. Social support and security/ confidence were defined as self-assessed answers to whether they regarded themselves as having support/ confidence/feeling secure enough to give their child a good start, and were used in the analysis as nominal variables (transformed from a 6-point Likert scale).
Severe life events were derived from the answers ('yes' or 'no') to the question 'Have you experienced any severe lifeevent during the past 2.5 years?' Participants were then given options: death of family member/relative, divorce, severe disease/accident, violence, unemployment, other. The variables passive and negative were derived from selfestimated attitudes concerning whether they regarded themselves to be active/passive and negative/positive, respectively, towards ABIS participation. Lack of knowledge was derived from questions in which the respondents were asked to respond to three accurate statements of the basic aims and methods of the ABIS study: variable defined as having two incorrect answers (2), 1 incorrect answer (1), no correct answer (0). A test including all three statements gave similar results: w 2 ¼ 39.093, Po0.001. Low selfassessed understanding was derived from a question asking them to self-assess their level of understanding of the ABIS study's main aims. Experienced pressure ('yes'/'no') was derived from a question asking them to state whether they had experienced any pressure with regard to their current participation in the longitudinal ABIS-study. Concern was derived from a question about how the respondents feel regarding the information they have previously submitted by writing a 1-year diary and by answering questionnaires (answers on a 6-point Likert scale).
Statistical analysis
The coding and analysis was conducted using SPSS 11. The initial aim was to explore potential bivariate correlations through w 2 -analysis and independent t-tests (displayed in Table 2 ). Logistic regression models were used to explore predictors and calculate Odds Ratios (OR) ( Table 3) . Two sets of logistic regression models were used based on different samples. The first model included both the identified associated variables (Table 1) , including potential confounders on the whole sample of 7206 (backward stepwise LR). We generally considered all variables in the 5-year main questionnaire as potential confounders. Owing mainly to the skewed data distribution we then used the main predictors (concern with natural history data, lack of knowledge, experienced pressure to participate, and the child's disease development) in a smaller model including the 2% (n ¼ 142) who do not want information and the larger group of participants who want information regardless of whether preventive measures/interventions are available (n ¼ 5328). Before entering the logistic regression calculation we made an additional exploration of potential confounders, in case the data would be more sensitive to potentially important variables with the more stringent dichotomisation of the dependent variable. The second model was run with the 'enter' procedure. The Hosmer and Lemenshow test was used for model validation. Both models had a P-value of 0.6 or higher. To avoid mass significance we have generally considered a P-value of 0.01 or less as statistically significant.
Results
Participants characteristics' are shown in Table 1 . There were no significant differences between the groups regarding demographic or general background data: maternal age (range 24 -54, mean 37.6 years), education, parity, family 'The right not to know' U Swartling et al relationships, professional status or family history of T1DM. Paternal age yielded a slightly higher mean (39.9, range 24 -66). Two percent (n ¼ 142) of respondents stated that they did not want to know whether their child was at high risk of developing diabetes. 24.1% (n ¼ 1736) marked the alternative 'Yes, I/we want to be informed if there is an effective prevention/intervention measure', while the remaining 73.9% (n ¼ 5328) wished to be informed regardless of any available intervention/prevention. Table 2 report that the group of 2% was not associated with any of the psychosocial variables incorporated in the clinical main questionnaire: parental satisfaction, social support, feeling secure and confident, experience of any severe life events during the past 2,5 years, maternal concern about the child's disease development or other concerns related to the child's development or childhood/adolescence events.
We found, however, that the negative attitude towards being informed about high-risk status was due to factors associated with regarding oneself as passive, negative, and experiencing concern with participation in the ABIS-study (ro0.001), and concern with the natural history data, that is the clinical questionnaire data (ro0.001).
In addition, there was also an association with lack of knowledge about the ABIS study (ro0.001) and a low level of self-assessed understanding of the ABIS study's aims and methods (ro0.01), as well as some experienced pressure to participate in the study (ro0.001).
We included all variables in the first logistic regression analysis (backward stepwise) in order to differentiate among the variables and also to investigate whether any potential confounders existed. The results identified concern with natural history data (OR ¼ In the second logistic regression model a smaller sample (n ¼ 5470) was used, filtering the group of participants stating that they want to be informed only if some intervention or prevention exists (n ¼ 1736). The result yielded odds ratios for lack of knowledge (OR ¼ 3.82; CI: 2.39 -6.08; ro0.001), experienced pressure (OR ¼ 2.54; CI: 1.41 -4.59; r ¼ 0.002), the child's development of a severe or chronic disease (OR ¼ 2.63; CI: 1.34 -5.14; r ¼ 0.005) and for concern with natural history data (OR ¼ 2.18; CI: 1.04 -4.56; r ¼ 0.038).
Discussion
Although widely defended, the view that there is a legitimate general right not to know is controversial. This paper presents survey data on the attitude of more than 7200 participants regarding information about their children's potential risk status in the context of a specific longitudinal cohort screening. While the majority were positive towards disclosing information, two percent of the study population stated that they did not want to be informed regardless of whether a prevention or intervention was available. Statistical analysis shows that this group is significantly associated with having ill children, having a negative attitude towards the study in which they participate, dissatisfaction with information, low selfassessed understanding, lack of knowledge of the study, concern with research data, and having experienced pressure to participate. The logistic regression model identified four of these as primary factors: concern with questionnaire data, factual lack of knowledge, experience of pressure to participate, and having children with a prominent disease history.
The data presented here provide reason to doubt that expressed preferences for not wanting information are autonomous. Those who do not want to know regardless of what can be done are strongly associated with factors indicating that they are driven by fear and ignorance; they lack knowledge and show concern with the extensive environmental data they provide, and their child has also, to a significant degree, been more ill than the children of ' The right not to know' U Swartling et al other participants. Furthermore they have experienced pressure either in their original decision to participate or during the 5 years of participation. Their autonomy in this case can therefore be questioned -they do not conform to the ideal of autonomous agents exercising their rights in a knowledgeable and free manner. To simply respect their wish not to know seems like a poor response to their predicament, rather they seem to be in need of extensive support in order to increase their understanding of the study and to strengthen their autonomy, and to leave the study if they wish.
Disclosure is in many cases a precondition for invitation to follow-up studies. However, informing about high-risk status is problematic since not everyone wants the information (and some only on the prerequisite that an effective intervention is available). On the other hand, withholding such important information is also problematic since many people want to know. A way out of this dilemma is to ask beforehand about people's attitudes towards high-risk information. In this way, the act of asking does not imply that something has already been found, and as such, autonomy can be respected regardless of people's attitudes towards the information. This is the approach we have chosen.
However, as we have seen, it is not obvious how to act on the attitudes expressed since it is not always clear that an This, we would like to argue, is sufficient reason not to promote a default solution where people's expressed wishes not to know are taken at face value. Participants' 'no' to high-risk information may call for a more nuanced response. It is a complex matter to balance competing interests but this has to be done; to grant a party a principal right not to know would cloud the issues at stake. It might even fail to promote the parents' autonomy.
Limitations
The results and the analysis rely heavily on self-reported data from the clinical questionnaire. We cannot exclude that some of the answers to the questions incorporated have been either under-reported or over-reported. It must also be recognised that there may be other potential confounders that can contribute to our understanding. Our data suggest the need to be cautious when using concepts like rights and autonomous choice to motivate a particular line of action in research settings such as the ABIS study. More research is needed to clarify the reasons behind declining to know about high-risk status.
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